Prostate Cancer Stem Cells: Biology and Treatment Implications.
chemotherapy
prostate cancer
radiotherapy
stem cells
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
04 Oct 2023
04 Oct 2023
Historique:
received:
06
09
2023
revised:
30
09
2023
accepted:
01
10
2023
medline:
23
10
2023
pubmed:
14
10
2023
entrez:
14
10
2023
Statut:
epublish
Résumé
Stem cells differentiate into mature organ/tissue-specific cells at a steady pace under normal conditions, but their growth can be accelerated during the process of tissue healing or in the context of certain diseases. It is postulated that the proliferation and growth of carcinomas are sustained by the presence of a vital cellular compartment resembling stem cells residing in normal tissues: 'stem-like cancer cells' or cancer stem cells (CSCs). Mutations in prostate stem cells can lead to the formation of prostate cancer. Prostate CSCs (PCSCs) have been identified and partially characterized. These express surface markers include CD44, CD133, integrin α2β1, and pluripotency factors like OCT4, NANOG, and SOX2. Several signaling pathways are also over-activated, including Notch, PTEN/Akt/PI3K, RAS-RAF-MEK-ERK and HH. Moreover, PCSCs appear to induce resistance to radiotherapy and chemotherapy, while their presence has been linked to aggressive cancer behavior and higher relapse rates. The development of treatment policies to target PCSCs in tumors is appealing as radiotherapy and chemotherapy, through cancer cell killing, trigger tumor repopulation via activated stem cells. Thus, blocking this reactive stem cell mobilization may facilitate a positive outcome through cytotoxic treatment.
Identifiants
pubmed: 37834336
pii: ijms241914890
doi: 10.3390/ijms241914890
pmc: PMC10573523
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Oncol Lett. 2019 Apr;17(4):4024-4033
pubmed: 30930999
Exp Cell Res. 2011 Nov 1;317(18):2671-82
pubmed: 21871886
Lab Invest. 2000 Aug;80(8):1243-50
pubmed: 10950115
BMC Immunol. 2015 Jan 31;16:1
pubmed: 25636521
ACS Appl Mater Interfaces. 2016 Jul 20;8(28):17793-804
pubmed: 27348241
Prostate. 2007 May 1;67(6):653-60
pubmed: 17342746
Science. 2004 Nov 26;306(5701):1568-71
pubmed: 15567866
Cell. 2008 May 16;133(4):704-15
pubmed: 18485877
Cell Biosci. 2021 May 17;11(1):87
pubmed: 34001269
Nat Rev Urol. 2018 Apr;15(4):222-234
pubmed: 29460925
Stem Cell Res Ther. 2020 Jun 26;11(1):258
pubmed: 32586404
Prostate. 2023 Apr;83(5):440-453
pubmed: 36541373
Cell. 2007 May 4;129(3):465-72
pubmed: 17482542
Eur J Pharmacol. 2009 Dec 25;625(1-3):31-40
pubmed: 19835865
Int J Cancer. 2006 Oct 15;119(8):1858-62
pubmed: 16721785
Med Oncol. 2015 Mar;32(3):74
pubmed: 25698533
Front Immunol. 2020 Aug 07;11:1280
pubmed: 32849491
Cancer Res. 2003 Apr 15;63(8):1981-9
pubmed: 12702592
Oncotarget. 2017 Oct 26;8(61):104182-104192
pubmed: 29262631
Cancer Res. 2014 May 15;74(10):2763-72
pubmed: 24686169
Int J Biol Sci. 2013 May 15;9(5):472-9
pubmed: 23781140
Am J Pathol. 2010 Jun;176(6):2584-494
pubmed: 20431026
Nature. 2009 Sep 24;461(7263):495-500
pubmed: 19741607
Nat Med. 2003 May;9(5):554-61
pubmed: 12692543
Pol J Pathol. 2014 Dec;65(4):291-5
pubmed: 25693083
Biomedicines. 2021 Feb 04;9(2):
pubmed: 33557143
PLoS Biol. 2003 Dec;1(3):E59
pubmed: 14691534
Cells. 2020 Jun 10;9(6):
pubmed: 32531951
Genome Med. 2022 Sep 05;14(1):102
pubmed: 36059000
PLoS One. 2013;8(1):e52993
pubmed: 23308129
Endocrinology. 2014 Mar;155(3):805-17
pubmed: 24424067
Mol Cancer Res. 2017 Oct;15(10):1308-1317
pubmed: 28607007
Biomacromolecules. 2021 Apr 12;22(4):1374-1388
pubmed: 33724003
Exp Biol Med (Maywood). 2013 Mar;238(3):324-38
pubmed: 23598979
Cancer Cell. 2010 Jul 13;18(1):11-22
pubmed: 20579941
Cancer Res. 2018 Jun 15;78(12):3147-3162
pubmed: 29700003
Cancer Chemother Pharmacol. 2016 Dec;78(6):1297-1304
pubmed: 27826729
Sci Rep. 2021 Jan 14;11(1):1465
pubmed: 33446896
Int J Cancer. 2012 Mar 1;130(5):1021-8
pubmed: 21387309
J Natl Cancer Inst. 2014 Jan;106(1):djt356
pubmed: 24309006
Cell Death Dis. 2013 Oct 24;4:e875
pubmed: 24157869
Nat Rev Urol. 2017 Nov;14(11):683-696
pubmed: 28895566
Nat Rev Cancer. 2005 Apr;5(4):275-84
pubmed: 15803154
J Exp Clin Cancer Res. 2018 Jul 27;37(1):173
pubmed: 30053872
Int J Mol Sci. 2013 Jul 04;14(7):13979-4007
pubmed: 23880852
Int J Hematol. 2016 Feb;103(2):122-8
pubmed: 26692196
Nanomedicine. 2020 Jul;27:102192
pubmed: 32229215
Mol Cancer Res. 2017 Feb;15(2):128-140
pubmed: 27856956
J Biol Chem. 2015 Jul 17;290(29):17745-17752
pubmed: 26032419
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8
pubmed: 12629218
Urol Int. 2021;105(5-6):337-353
pubmed: 32957106
Int J Nanomedicine. 2019 Sep 16;14:7549-7560
pubmed: 31571863
Cancer Res. 2003 Sep 15;63(18):5821-8
pubmed: 14522905
Cancer Biol Med. 2023 Jun 5;20(6):
pubmed: 37282627
Nature. 2007 Jul 19;448(7151):318-24
pubmed: 17554336
Prostate. 2014 Nov;74(15):1498-505
pubmed: 25175483
J Biol Chem. 2004 Jun 4;279(23):24733-44
pubmed: 15028713
World J Gastroenterol. 2015 Nov 21;21(43):12334-50
pubmed: 26604641
J Exp Clin Cancer Res. 2023 Jul 29;42(1):187
pubmed: 37507762
Adv Drug Deliv Rev. 2013 Nov;65(13-14):1763-83
pubmed: 24120657
Elife. 2015 Sep 16;4:
pubmed: 26374986
Prostate. 2002 Jun 1;51(4):241-6
pubmed: 11987152
Int J Oncol. 2018 Jul;53(1):99-112
pubmed: 29658567
Exp Mol Pathol. 2022 Apr;125:104757
pubmed: 35339454
Int J Mol Sci. 2022 Oct 25;23(21):
pubmed: 36361635
Cochrane Database Syst Rev. 2015 Sep 30;(9):CD006536
pubmed: 26419913
Int J Mol Sci. 2022 Apr 26;23(9):
pubmed: 35563163
J Clin Oncol. 2012 Jul 1;30(19):2348-53
pubmed: 22529266
Prostate. 2010 Apr 1;70(5):491-501
pubmed: 19938015
Cancer Res. 2015 Apr 1;75(7):1482-94
pubmed: 25670168
Exp Cell Res. 2011 Nov 15;317(19):2725-31
pubmed: 21851818
Environ Health Perspect. 1993 Dec;101 Suppl 5:15-26
pubmed: 7516873
Ernst Schering Found Symp Proc. 2006;(5):155-79
pubmed: 17939301
J Biol Chem. 2009 May 1;284(18):11755-9
pubmed: 19117948
Neoplasia. 2006 Sep;8(9):716-24
pubmed: 16984729
Stem Cells. 2012 Jan;30(1):2-9
pubmed: 22162299
Stem Cells. 2018 Oct;36(10):1457-1474
pubmed: 29845679
J Cell Sci. 2004 Jul 15;117(Pt 16):3539-45
pubmed: 15226377
Dev Cell. 2019 Feb 11;48(3):329-344.e5
pubmed: 30595538
Am J Clin Exp Urol. 2014 Dec 09;2(4):273-85
pubmed: 25606573
Oncoimmunology. 2018 May 7;7(7):e1440169
pubmed: 29900044
Int J Cancer. 2018 Aug 1;143(3):645-656
pubmed: 29488214
Int J Clin Exp Pathol. 2018 Oct 01;11(10):4957-4966
pubmed: 31949572
Cancer Res Commun. 2023 Jul 19;3(7):1286-1311
pubmed: 37476073
Cancer Res. 2005 Dec 1;65(23):10946-51
pubmed: 16322242
Cancer Res. 2011 Jul 1;71(13):4640-52
pubmed: 21712410
Clin Cancer Res. 2010 Jun 15;16(12):3153-62
pubmed: 20530697
Med Oncol. 2023 Jun 1;40(7):194
pubmed: 37264204
Dev Cell. 2005 Nov;9(5):617-28
pubmed: 16256737
Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):268-73
pubmed: 19116269
Pharmacol Res. 2012 Aug;66(2):105-43
pubmed: 22569528
Oncotarget. 2016 Dec 20;7(51):84286-84298
pubmed: 27713179
Mol Cell Biol. 2016 May 31;36(12):1734-9
pubmed: 27090640
PLoS One. 2013 Apr 19;8(4):e61716
pubmed: 23620784
Clin Cancer Res. 2010 Dec 1;16(23):5692-702
pubmed: 21138868
Cancer Res. 2013 Aug 15;73(16):5288-98
pubmed: 23824741
Int J Mol Sci. 2020 Dec 16;21(24):
pubmed: 33339129
Front Cell Dev Biol. 2021 May 28;9:649205
pubmed: 34124039
Proc Natl Acad Sci U S A. 2013 May 14;110(20):8105-10
pubmed: 23620512
Anticancer Drugs. 2018 Oct;29(9):871-879
pubmed: 29944470
Biol Res. 2012;45(3):297-305
pubmed: 23283439
Am J Surg Pathol. 2016 Feb;40(2):244-52
pubmed: 26492179
Nature. 1994 Feb 17;367(6464):645-8
pubmed: 7509044
Tissue Eng Part B Rev. 2016 Apr;22(2):160-71
pubmed: 26559963
Front Oncol. 2021 Jan 11;10:604124
pubmed: 33505918
Exp Oncol. 2020 Jun;42(2):94-100
pubmed: 32602285
Br J Cancer. 2013 Dec 10;109(12):3023-33
pubmed: 24220693
Curr Mol Med. 2009 Sep;9(7):873-86
pubmed: 19860666
Cancer Lett. 2015 Dec 1;369(1):20-7
pubmed: 26341688
Clin Cancer Res. 2014 Sep 1;20(17):4625-35
pubmed: 24987058
J Cell Sci. 2001 Nov;114(Pt 21):3865-72
pubmed: 11719553
Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20882-7
pubmed: 19088204
Clin Immunol. 2013 Oct;149(1):156-68
pubmed: 23994769
Adv Biol Regul. 2016 Jan;60:64-87
pubmed: 26525204
Cell Stem Cell. 2015 Mar 5;16(3):225-38
pubmed: 25748930
Cancer Cell Int. 2018 Nov 12;18:177
pubmed: 30459527
Prostate. 2012 May 15;72(7):713-20
pubmed: 21882211
Exp Cell Res. 2020 Mar 15;388(2):111850
pubmed: 31954695
Med Hypotheses. 2002 Oct;59(4):422-8
pubmed: 12208182
Oncogene. 2010 Sep 2;29(35):4947-58
pubmed: 20562913
Cell. 2015 Nov 5;163(4):1011-25
pubmed: 26544944
Prostate. 2000 Mar 1;42(4):274-9
pubmed: 10679756
Prostate. 2015 Feb;75(2):161-74
pubmed: 25307492
Int J Mol Sci. 2017 Feb 13;18(2):
pubmed: 28208838
Adv Exp Med Biol. 2019;1210:351-378
pubmed: 31900917
Crit Rev Eukaryot Gene Expr. 2012;22(2):131-48
pubmed: 22856431
Nat Commun. 2013;4:1623
pubmed: 23535644
Semin Cell Dev Biol. 2005 Aug-Oct;16(4-5):554-63
pubmed: 16144692
Cancer Res. 2002 Oct 1;62(19):5551-8
pubmed: 12359767
Prostate. 2014 May;74(5):488-96
pubmed: 24375374
Int J Biol Sci. 2014 Sep 06;10(9):1007-17
pubmed: 25210499
Br J Cancer. 2008 Feb 26;98(4):756-65
pubmed: 18268494
Oncotarget. 2015 Jan 1;6(1):171-84
pubmed: 25426558
Cancers (Basel). 2023 Mar 06;15(5):
pubmed: 36900412
Curr Drug Metab. 2006 Aug;7(6):629-60
pubmed: 16918317
Clin Cancer Res. 1997 May;3(5):805-15
pubmed: 9815753
J Clin Invest. 2011 Apr;121(4):1298-312
pubmed: 21436587
Cancer Res. 2005 Mar 1;65(5):1755-60
pubmed: 15753371
Cell Death Differ. 2015 Jun;22(6):898-911
pubmed: 25012501
J Transl Med. 2021 May 13;19(1):206
pubmed: 33985534
Cells. 2022 Aug 07;11(15):
pubmed: 35954292
Nature. 2008 Dec 11;456(7223):804-8
pubmed: 18946470
Clin Exp Metastasis. 2012 Jan;29(1):1-9
pubmed: 21953074
Curr Genomics. 2011 Nov;12(7):486-505
pubmed: 22547956
Eur Urol. 2000 Nov;38(5):555-62
pubmed: 11096236
Stem Cells Dev. 2013 Feb 15;22(4):611-21
pubmed: 22897112
Cancer Res. 2007 May 15;67(10):4807-15
pubmed: 17510410
Oncol Rep. 2019 May;41(5):2689-2702
pubmed: 30864728
J Med Chem. 2019 Sep 26;62(18):8392-8411
pubmed: 30986059
Clin Genitourin Cancer. 2015 Apr;13(2):130-6
pubmed: 25450039
Lab Invest. 2010 Feb;90(2):234-44
pubmed: 20010854
Tumour Biol. 2014 May;35(5):3945-51
pubmed: 24420150
Clin Cancer Res. 2007 Jul 15;13(14):4042-5
pubmed: 17634527
Precis Clin Med. 2021 Jan 28;4(1):25-34
pubmed: 33842835
Nat Rev Cancer. 2021 Aug;21(8):526-536
pubmed: 34103704
Cells. 2019 Mar 30;8(4):
pubmed: 30935014
Chin J Integr Med. 2023 Oct;29(10):914-923
pubmed: 37357241
Exp Cell Res. 2004 May 1;295(2):469-87
pubmed: 15093745
PLoS One. 2009 May 22;4(5):e5662
pubmed: 19461893
Cancer Res. 1992 Nov 15;52(22):6182-7
pubmed: 1384957